Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia

Journal of Clinical Oncology

Volumn 20, Issue 10, 2002, Pages 2464-2471

  Linker, Charles ^a   Damon, Lloyd ^a   Ries, Curt ^a   Navarro, Willis ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LEUKOCYTE COUNT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHOTREXATE; MIDDLE AGED; PREDNISONE; REMISSION INDUCTION; RISK FACTORS; TREATMENT OUTCOME; VINCRISTINE;

EID: 0037092959     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.07.116     Document Type: Article

References (25)

1. The biology and treatment of acute lymphoblastic leukemia in adults
2. Treatment of adult acute lymphoblastic leukemia with intensive chemotherapy: A follow-up report
3. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811
4. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults
5. A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: The Memorial Hospital experience since 1969
6. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: An analysis of a prospective trial including 562 tested patients (LALA87)
7. Prospective karyotype analysis in adult acute lymphoblastic leukemia: The Cancer and Leukemia Group B experience
8. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukemia on MRC trial UKALL XA
9. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hematologic findings and outcome-A collaborative study of the Groupe Français de Cytogénétique Hématologique
10. Results of treatment with hyper-CVAD. A dose-intensive regimen, in adult acute lymphocytic leukemia
11. High-dose anthracycline induction in adult acute lymphocytic leukemia
12. A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111
13. Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone
14. Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy
15. Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia
16. Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin
17. The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia
18. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
19. Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
20. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: Results of German multicenter trials GMALL 03/87 and 04/89
21. Single versus double autologous BMT/PBSCT in patients with BCR-ABL positive acute lymphoblastic leukemia
22. Autologous stem cell transplantation for high-risk adult acute lymphoblastic leukemia (ALL)
23. Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia
24. Small noncleaved cell lymphoma and leukemia in adults: A retrospective study of 65 adults treated with the LMB pediatric protocols
25. Improved outcome in adult B-cell acute lymphoblastic leukemia